Shaji Kumar on Later Lines of Treatment for Myeloma

Shaji Kumar, MDПодробнее

Shaji Kumar: Comparing KRd With VRd in Newly Diagnosed MyelomaПодробнее

Dr. Shaji Kumar on Novel Frontline Treatment Options in Multiple MyelomaПодробнее

Dr. Shaji Kumar on Upfront Combination Treatments in Multiple MyelomaПодробнее

Shaji Kumar on Recent Clinical Trial Developments in MyelomaПодробнее

MCP 60 Seconds With Dr Shaji Kumar on Muiltple MyelomaПодробнее

Shaji Kumar on the Changing Immunotherapy Landscape in MyelomaПодробнее

Dr. Kumar: Results of the ENDURANCE Trial Support Standard of Care Treatment for MyelomaПодробнее

Shaji Kumar, MD, discusses sequencing agents in the treatment of multiple myelomaПодробнее

Shaji Kumar, ASH 2019: Advances in treatment approaches and guidelines for multiple myelomaПодробнее

Shaji Kumar, MD, discusses the most exciting treatment options for multiple myeloma todayПодробнее

Shaji Kumar, ASCO 2018 – Advances in treatment approaches and guidelines for multiple myelomaПодробнее

Updates in Multiple Myeloma - Dr. Shaji Kumar, Part 1Подробнее

Multiple Myeloma Update | Shaji Kumar, MD | 2022 West Oncology | Updates for APPs & NursesПодробнее

Shaji Kumar, MD, explains how immunotherapies are being integrated into treatment algorithms for MMПодробнее

Shaji Kumar, MD, shares the take home message for physicians treating 1st line multiple myelomaПодробнее

Shaji Kumar, MD, shares results of the Phase 3 study regarding 1st line multiple myeloma treatmentПодробнее

Shaji Kumar, MD, shares his thoughts on whether multiple myeloma can be cured one dayПодробнее

Shaji Kumar, MD, explains the impact personalized medicine will have on treatment of MMПодробнее